2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Breast
1
Conditions
Colorectal Neoplasms
25
Neoplasm Metastasis
15
Neoplasms
13
Rectal Neoplasms
8
Colorectal Cancer Metastatic
7
Colonic Neoplasms
6
Ovarian Neoplasms
5
Lymphoma, Non-Hodgkin
5
Uveal Melanoma
4
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Melanoma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Fallopian Tube Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Burkitt Lymphoma
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Stomach Neoplasms
3
Prostatic Neoplasms
3
Lung Neoplasms
3
Glioblastoma
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Interventions
Gemcitabine
685
130-nm albumin-bound paclitaxel
199
Fluorouracil
190
Oxaliplatin
177
Albumin-Bound Paclitaxel
154
Capecitabine
137
Leucovorin
133
Irinotecan
114
Radiotherapy
96
Taxes
85
pembrolizumab
81
Cisplatin
73
Erlotinib Hydrochloride
70
Radiosurgery
69
Nivolumab
56
Drug Therapy
56
Bevacizumab
54
Magnetic Resonance Spectroscopy
51
Cyclophosphamide
50
folfirinox
45
Specimen Handling
43
Docetaxel
42
Cetuximab
40
Biopsy
39
irinotecan sucrosofate
38
S 1 (combination)
36
Pancreaticoduodenectomy
35
Blood Specimen Collection
34
Surgical Procedures, Operative
31
Paclitaxel
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
aflibercept
×
Clear all
NCT01843725
2018-01-31
MOMENTUM1
Jules Bordet Institute
Phase 1
Completed
37 enrolled
NCT00574275
2016-06-07
VANILLA
Sanofi
Phase 3
Terminated
546 enrolled
14 charts